CARA THERAPEUTICS INC. - COMMON STOCK

Cara Therapeutics Announces Exploration of Strategic Alternatives

11 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CARA THERAPEUTICS INC. - COMMON STOCK

17 Jun 2024 09:53:14 By NetDania Notify

NetDania - New 12 months Low: CARA THERAPEUTICS INC. - COMMON STOCK

14 Jun 2024 10:22:03 By NetDania Notify

NetDania - New 12 months Low: CARA THERAPEUTICS INC. - COMMON STOCK

13 Jun 2024 09:46:05 By NetDania Notify

Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica

12 Jun 2024 16:01:00 By Nasdaq GlobeNewswire

Cara Therapeutics Reports First Quarter 2024 Financial Results

13 May 2024 16:01:00 By Nasdaq GlobeNewswire

Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024

06 May 2024 07:00:00 By Nasdaq GlobeNewswire

Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

02 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024

07 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results

04 Mar 2024 16:01:00 By Nasdaq GlobeNewswire

Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024

12 Feb 2024 16:01:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CARA THERAPEUTICS INC. - COMMON STOCK

25 Jan 2024 10:06:25 By NetDania Notify

Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026

22 Jan 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CARA THERAPEUTICS INC. - COMMON STOCK

18 Jan 2024 09:51:19 By NetDania Notify

NetDania - New 12 months Low: CARA THERAPEUTICS INC. - COMMON STOCK

16 Jan 2024 09:59:23 By NetDania Notify

NetDania - New 12 months Low: CARA THERAPEUTICS INC. - COMMON STOCK

12 Jan 2024 15:31:41 By NetDania Notify

NetDania - New 12 months Low: CARA THERAPEUTICS INC. - COMMON STOCK

18 Dec 2023 09:56:56 By NetDania Notify

Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis

18 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

Cara Therapeutics Reports Third Quarter 2023 Financial Results

13 Nov 2023 16:01:00 By Nasdaq GlobeNewswire

Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty

02 Nov 2023 07:00:45 By Nasdaq GlobeNewswire